Which is better Aromasin or Femara?
Which is better Aromasin or Femara?
Women with pre-existing heart disease who take an AI may be at higher risk of having a heart problem. For medical questions, we encourage you to review our information with your doctor. Aromatase inhibitors are delivered in tablet form and prescribed as a once-daily dose. Aromasin should be taken after a meal as fat in food aids in the drug’s absorption. Aromasin and Femara have both similar and different side effects.
- When used to lower breast cancer risk, these drugs are typically taken for 5 years.
- This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
- Women with pre-existing heart disease who take an AI may be at higher risk of having a heart problem.
Your doctor may prescribe Aromasin with other medications for breast cancer. These can include everolimus (Afinitor) or, rarely, tamoxifen. These medications may be used with Aromasin if your cancer has gotten worse with other treatments. Exemestane (Aromasin) and tamoxifen are both prescription drugs used to treat certain kinds of breast cancer. In studies of the drug, weight gain occurred when Aromasin was used to treat advanced breast cancer. One approach to hormone therapy is to stop the hormones from attaching to the receptors on the cancer cells.
What should I know about Aromasin vs. Arimidex?
Your doctor may also suggest other medications to prevent bone loss. Before taking Aromasin, be sure to tell your doctor about all medications you take, including prescription and over-the-counter types. Also describe any vitamins, herbs, or supplements you use. Your doctor or pharmacist can tell you about any interactions these items may cause. Aromasin treats breast cancer by blocking the effects of estrogen.
It can also be used in premenopausal women having ovarian suppression. For example, they might be a reasonable option for women who have an increased risk of blood clots and therefore should not take tamoxifen or raloxifene. Additional studies are underway to determine whether aromatase inhibitors may reduce the risk of breast cancer in people with genetic mutations that increase breast cancer risk.
Help us end cancer as we know it, for everyone.
A breast cancer that’s sensitive to progesterone is called progesterone receptor positive, also called PR positive. Clinical trials have shown that two aromatase inhibitors – anastrozole and exemestane – can lower breast cancer risk in women who have never been diagnosed with the disease. https://premiumink.net/2024/03/13/study-shows-trestolone-acetate-50mg-dosage-offers/ However, these drugs have not yet received FDA approval for this use. Pre-menopausal women with breast cancer fueled by estrogen are prescribed tamoxifen, or less frequently, raloxifene. Like aromatase inhibitors, these drugs work against estrogen, but in a different way.
Unlike tamoxifen and raloxifene, AIs tend to speed up bone thinning, which can lead to osteoporosis. People with osteoporosis are more likely to have broken bones. Because of this, doctors often recommend checking bone density before starting one of these drugs.
If you have questions about how to pay for your prescription, talk with your doctor or pharmacist. You can also visit the Aromasin manufacturer’s website to see if they have support options. You may have questions about Aromasin and your treatment plan.
When the hormones can’t access the cancer cells, the cancer’s growth may slow and the cells may die. Before the menopause, oestrogen is mainly produced in the ovaries. After the menopause, the ovaries no longer produce oestrogen, but some oestrogen is still made in body fat. This process involves an enzyme (a type of protein) called aromatase.
In large studies, both anastrozole and exemestane have been shown to lower breast cancer risk in postmenopausal women who are at increased risk. Aromatase inhibitors are the most effective medications today for treating or preventing the recurrence of estrogen-fueled breast cancers in post-menopausal women. Aromatase inhibitors are among the most effective medications today for treating or preventing the recurrence of estrogen-fueled breast cancers in post-menopausal women. Cancer medications given by vein (through an IV) or injection (under the skin or into a muscle) are usually covered under a health insurance plan’s medical benefit.